Related Experiment Video
Updated: Aug 5, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Two Mechanisms One Molecule: Developing a 'Truly' Bifunctional Degrader Targeting Rpn13 and CRBN
Cody A Loy1,2, Shawn E Vinogradsky1,2, Darci J Trader1,2,3
1Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California92617, United States.
Researchers developed "Truly" degraders, novel bifunctional molecules for targeted protein degradation. These molecules simultaneously engage ubiquitin-dependent and -independent pathways, offering a new strategy for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Targeted protein degradation (TPD) is a key therapeutic strategy, but current methods primarily rely on ubiquitin ligases.
- Previous work introduced ByeTACs for E-ligase independent degradation.
- Existing TPD approaches have limitations in targeting specific proteins.
Purpose of the Study:
- To develop a new class of bifunctional molecules, "Truly" degraders, that utilize dual degradation mechanisms.
- To investigate the efficacy of "Truly" degraders in degrading disease-relevant proteins.
- To explore the potential of "Truly" degraders in cancer therapy.
Main Methods:
- Design and synthesis of "Truly" degraders, combining ligands for Rpn13 and cereblon (CRBN).
- Structure-guided optimization of linker length for efficient substrate processing.
- Evaluation of degradation efficacy and cytotoxicity in various cancer cell lines.
Main Results:
- The PEG4 derivative (Truly-4) effectively depleted Rpn13 and CRBN in cancer cells.
- Truly-4 achieved noncovalent degradation of full-length Rpn13, a novel approach.
- Degradation of Rpn13 occurred via CRBN-dependent E3 ligase activity, while CRBN degraded independently.
- Truly-4 exhibited selective cytotoxicity in cancer cells but not healthy cells.
Conclusions:
- "Truly" degraders represent a new class of bifunctional molecules for targeted protein degradation.
- Dual-mechanism degradation offers a strategy to uncouple target engagement from toxicity.
- Proteasome receptors are viable targets for selective destruction of disease-related proteins.
Related Concept Videos
Radical Chain-Growth Polymerization: Mechanism
Restarting Stalled Replication Forks
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Ribozymes
Ribozymes can be...
Long-patch Base Excision Repair
Radical Chain-Growth Polymerization: Overview

